We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DOW Agrees to Divest 50% Ownership in DowAksa Joint Venture
Read MoreHide Full Article
Key Takeaways
DOW will divest its 50% stake in DowAksa to partner Aksa Akrilik Kimya for $125 million.
The deal aligns with DOW's best-owner strategy, focusing on core downstream businesses.
The transaction reflects a 10x 2025 EBITDA valuation and is expected to close in Q3 2025.
Dow Inc. (DOW - Free Report) signed an agreement to sell its 50% interest in DowAksa Advanced Composites Holdings BV (DowAksa) to the other 50% joint venture partner, Aksa Akrilik Kimya Sanayii A.S.
The sale proceeds are estimated to be $125 million, which will be used to support DOW’s balanced capital allocation approach. This reflects an enterprise value of around 10x the estimated 2025 operating EBITDA.
The sale of the stake in the joint venture created in 2012 is expected to close in the third quarter of 2025. DOW’s decision to exit is rooted in its best-owner mindset strategy of focusing on its core, high-value downstream businesses.
DOW stock has lost 47.1% over the past year compared with the industry’s 24.9% decline.
Image Source: Zacks Investment Research
Dow, on its first-quarter call, said that it remains committed to disciplined execution and increased actions to boost profitability and support cash flow. It continues to take actions to address heightened macroeconomic and geopolitical uncertainties. Dow has delayed the construction of the Fort Saskatchewan Path2Zero project amid the prevailing market conditions.
Also, it is expanding the earlier announced review of European assets, mainly in polyurethanes, to address the challenging demand conditions and regulatory environment in the region. These new and earlier announced actions are expected to deliver roughly $6 billion in cash support.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 40.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 8.8% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DOW Agrees to Divest 50% Ownership in DowAksa Joint Venture
Key Takeaways
Dow Inc. (DOW - Free Report) signed an agreement to sell its 50% interest in DowAksa Advanced Composites Holdings BV (DowAksa) to the other 50% joint venture partner, Aksa Akrilik Kimya Sanayii A.S.
The sale proceeds are estimated to be $125 million, which will be used to support DOW’s balanced capital allocation approach. This reflects an enterprise value of around 10x the estimated 2025 operating EBITDA.
The sale of the stake in the joint venture created in 2012 is expected to close in the third quarter of 2025. DOW’s decision to exit is rooted in its best-owner mindset strategy of focusing on its core, high-value downstream businesses.
DOW stock has lost 47.1% over the past year compared with the industry’s 24.9% decline.
Image Source: Zacks Investment Research
Dow, on its first-quarter call, said that it remains committed to disciplined execution and increased actions to boost profitability and support cash flow. It continues to take actions to address heightened macroeconomic and geopolitical uncertainties. Dow has delayed the construction of the Fort Saskatchewan Path2Zero project amid the prevailing market conditions.
Also, it is expanding the earlier announced review of European assets, mainly in polyurethanes, to address the challenging demand conditions and regulatory environment in the region. These new and earlier announced actions are expected to deliver roughly $6 billion in cash support.
DOW’s Zacks Rank & Key Picks
DOW currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Balchem Corporation (BCPC - Free Report) . While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 40.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 8.8% in the past year.